Patient perspectives on molecular tumor profiling: "Why wouldn't you?"
Megan C BestNicole BartleyChris JacobsIlona JuraskovaDavid GoldsteinAinsley Janelle NewsonJacqueline SavardBettina MeiserMandy L BallingerChristine E NapierDavid M ThomasBarbara BieseckerPhyllis N Butownull nullPublished in: BMC cancer (2019)
Having advanced cancer seemed to abrogate any potential concerns about MTP. Participants valued the research for varied reasons, but this was secondary to their priority to survive. While no negative attitudes toward MTP emerged, limitations in understanding of genomics were evident.